Company facts
Early-stage
- Founded
- 2024
- Employees
- 2
- Headquarters
- United States
About
SynsoryBio is creating next generation, protein therapeutics that sense where they are in the body and only activate at diseased tissue. This technology platform has the potential to expand the therapeutic window of highly potent drugs and apply to many diseases such as cancer and autoimmune disorders.